Trafalgar International (GCAN) Cash & Equivalents Growth (1y) (2018 - 2026)
Trafalgar International (GCAN) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | -4.65% |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.89% |
| Dec 31, 2025 | -98.58% |
| Sep 30, 2025 | -65.71% |
| Jun 30, 2025 | -66.74% |
| Mar 31, 2025 | -64.27% |
| Dec 31, 2024 | -65.62% |
| Jun 30, 2024 | -66.64% |
| Dec 31, 2023 | -38.21% |
| Jun 30, 2023 | -22.64% |
| Dec 31, 2022 | -28.47% |
| Jun 30, 2022 | -41.16% |
| Dec 31, 2021 | 234.23% |
| Sep 30, 2021 | 155.47% |
| Jun 30, 2021 | 131.46% |
| Mar 31, 2021 | 7.25% |
| Dec 31, 2020 | 358.00% |
| Sep 30, 2020 | 289.62% |
| Jun 30, 2020 | 181.99% |
| Mar 31, 2020 | 79.06% |
| Dec 31, 2019 | -58.82% |